GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Diagnosticos da America DASA3.SA · BRL

Health Care · B3 · 🇧🇷 Brazil

Compare

3.40

+4.29%

Close of 9 Nov 2026, in BRL

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in BRL, from our data supplier.

FY2025

Revenue

BRL 11.17bn

FY2016FY2025

Net income

−BRL 1.15bn

FY2016FY2025

Free cash flow

−BRL 326.6m

FY2016FY2025

Shareholders' equity

BRL 6.87bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueBRL 11.17bnBRL 15.32bnBRL 14.25bnBRL 13.13bnBRL 10.42bnBRL 7.04bnBRL 4.36bnBRL 3.93bnBRL 3.40bnBRL 3.04bn
Gross profitBRL 3.39bnBRL 4.19bnBRL 3.89bnBRL 3.80bnBRL 3.12bnBRL 1.76bnBRL 1.55bnBRL 1.40bnBRL 1.16bnBRL 964.6m
Research and development————————BRL 51.1mBRL 33.6m
Operating incomeBRL 1.01bnBRL 1.01bnBRL 911.7mBRL 1.02bnBRL 88.5mBRL 132.1mBRL 393.0mBRL 352.7mBRL 336.1mBRL 300.0m
Net income−BRL 1.15bn−BRL 1.20bn−BRL 1.17bn−BRL 386.9m−BRL 226.6m−BRL 150.8mBRL 124.8mBRL 184.4mBRL 131.4mBRL 94.7m
Diluted earnings per share-0.92-0.94-1.56-0.69-0.38-0.310.400.590.380.29

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsBRL 18.56bnBRL 26.46bnBRL 26.21bnBRL 26.84bnBRL 23.25bnBRL 13.34bnBRL 8.84bnBRL 7.22bnBRL 6.25bnBRL 5.16bn
Cash and short-term investmentsBRL 2.67bnBRL 1.90bnBRL 1.69bnBRL 3.08bnBRL 3.61bnBRL 1.51bnBRL 877.6mBRL 1.08bnBRL 592.6mBRL 658.5m
Total liabilitiesBRL 11.67bnBRL 18.52bnBRL 18.88bnBRL 19.75bnBRL 15.70bnBRL 9.81bnBRL 5.58bnBRL 3.90bnBRL 2.93bnBRL 2.30bn
DebtBRL 8.84bnBRL 12.99bnBRL 13.29bnBRL 13.90bnBRL 9.77bnBRL 6.82bnBRL 3.74bnBRL 2.54bnBRL 1.79bnBRL 1.35bn
Shareholders' equityBRL 6.87bnBRL 7.93bnBRL 7.33bnBRL 7.08bnBRL 7.54bnBRL 3.54bnBRL 3.27bnBRL 3.34bnBRL 3.34bnBRL 2.86bn
Shares outstanding1,250m1,269m747m558m598m481m315m312m347m332m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−BRL 36.3mBRL 27.9m−BRL 963.6m−BRL 29.0mBRL 1.30bnBRL 766.5mBRL 699.4mBRL 530.3mBRL 653.2mBRL 841.9m
Capital spending−BRL 290.3m−BRL 538.5m−BRL 811.2m−BRL 1.14bn−BRL 905.8m−BRL 755.7m−BRL 504.7m−BRL 299.6m−BRL 254.4m−BRL 329.4m
Free cash flow−BRL 326.6m−BRL 510.6m−BRL 1.77bn−BRL 1.17bnBRL 392.4mBRL 10.8mBRL 194.6mBRL 230.7mBRL 398.8mBRL 512.5m
Dividends paid−BRL 5.0m−BRL 10.1m−BRL 341.9m−BRL 159.2m−BRL 220.3m−BRL 204.4m−BRL 157.9m−BRL 175.0m−BRL 35.9m−BRL 22.6m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueBRL 2.22bnBRL 2.22bnBRL 2.27bnBRL 2.61bnBRL 2.47bnBRL 3.83bnBRL 3.67bnBRL 3.97bn
Gross profitBRL 527.9mBRL 745.4mBRL 644.1mBRL 881.7mBRL 732.4mBRL 1.14bnBRL 846.1mBRL 1.14bn
Operating incomeBRL 239.5mBRL 295.4mBRL 109.8mBRL 390.5mBRL 148.2mBRL 342.2mBRL 10.5mBRL 392.8m
Net income−BRL 34.1m−BRL 1.9m−BRL 954.9mBRL 95.8m−BRL 178.6m−BRL 114.3m−BRL 830.9m−BRL 87.5m
Diluted earnings per share-0.03-0.00-0.760.08-0.14-0.09-0.65-0.07
Cash from operationsBRL 69.0m−BRL 74.0mBRL 5.0mBRL 434.0m−BRL 368.0m−BRL 107.0mBRL 222.0mBRL 226.0m
Capital spending−BRL 14.0m−BRL 15.0m−BRL 108.0m−BRL 78.0m−BRL 49.0m−BRL 53.0m−BRL 310.0m−BRL 107.0m
Free cash flowBRL 55.0m−BRL 89.0m−BRL 103.0mBRL 356.0m−BRL 417.0m−BRL 160.0m−BRL 88.0mBRL 119.0m
Total assetsBRL 17.12bnBRL 17.81bnBRL 18.56bnBRL 21.10bnBRL 20.22bnBRL 28.26bnBRL 26.46bnBRL 28.29bn
Cash and short-term investmentsBRL 958.7mBRL 1.71bnBRL 2.67bnBRL 2.55bnBRL 1.41bnBRL 3.58bnBRL 1.90bnBRL 2.82bn
DebtBRL 1.62bnBRL 7.43bnBRL 8.84bnBRL 9.86bnBRL 9.40bnBRL 15.11bnBRL 12.99bnBRL 14.02bn
Shareholders' equityBRL 6.84bnBRL 6.87bnBRL 6.87bnBRL 7.82bnBRL 7.61bnBRL 7.81bnBRL 7.93bnBRL 8.62bn

Financial ratios

Data as of 15 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2017FY2016FY2015FY2014
Gross margin30.4%27.4%27.3%28.9%29.9%24.9%————
Operating margin8.2%5.1%6.4%8.4%1.4%1.4%————
Net margin-10.3%-7.8%-8.2%-2.9%-2.2%-2.1%————
Return on equity-16.8%-15.1%-15.9%-5.5%-3.0%-4.3%————
Return on assets-6.2%-4.5%-4.4%-1.4%-1.0%-1.1%————
Free cash flow yield4.1%9.0%-4.1%40.0%74.3%63.8%————
Revenue growth-27.1%7.5%8.6%26.0%48.0%61.3%————
Earnings growth-3.9%2.8%201.4%70.8%50.2%-220.9%————
Current ratio1.24x1.55x1.25x1.25x0.99x1.40x————
Debt to equity1.18x1.36x1.50x1.75x1.11x1.63x————
Equity ratio37.0%30.0%28.0%26.4%32.4%26.5%————
Interest coverage0.56x0.42x0.48x0.63x0.24x0.27x————
R&D as a share of sales——————1.5%1.1%1.5%1.8%
Buybacks as a share of market value1.5%-69.8%-33.9%6.7%-24.4%-52.6%————

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-5.2%9.7%14.9%
Operating income-0.1%50.3%20.4%
Net income43.9%50.2%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin28.6%28.3%28.2%29.2%
Operating margin7.6%7.3%5.8%6.4%
Net margin-8.9%-7.2%-6.0%-4.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-3.0-1.2-3.7-11.9-53.4-69.343.713.721.818.6
Price to sales0.30.10.30.31.21.51.30.60.80.6

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 27 Dec 2022.

FY2022FY2021FY2019FY2018FY2017FY2016FY2015FY2014
Paid in the year0.0970.5870.5630.5610.140.100.0630.101
  • 4-for-1 split · 2 Feb 2010

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.